"At Fred Hutch, our interdisciplinary teams conduct high-impact science to achieve our mission: eliminating cancer and related diseases as causes of human suffering and death through prevention and curative treatments that are accessible to all patients."

During the past decade, Fred Hutchinson Cancer Research Center conducted 269 clinical trials. In the 10-year time frame, 269 clinical trials started and 210 clinical trials were completed, i.e. on average, 78.1% percent of trials that started reached the finish line to date. In the past 5 years, 109 clinical trials started and 92 clinical trials were completed. i.e. 84.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fred Hutchinson Cancer Research Center" #1 sponsor was "Fred Hutchinson Cancer Center" with 154 trials, followed by "SWOG Cancer Research Network" with 106 trials sponsored, "National Cancer Institute (NCI)" with 80 trials sponsored, "Children's Oncology Group" with 32 trials sponsored and "Celgene" with 32 trials sponsored. Other sponsors include 375 different institutions and companies that sponsored additional 176 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fred Hutchinson Cancer Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 348 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 31 trials as a collaborator, "National Marrow Donor Program" with 29 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 28 trials as a collaborator and "NRG Oncology" with 21 trials as a collaborator. Other collaborators include 320 different institutions and companies that were collaborators in the rest 184 trials.

According to Clinical.Site data, the most researched conditions in "Fred Hutchinson Cancer Research Center" are "Leukemia" (87 trials), "Lymphoma" (58 trials), "Myelodysplastic Syndromes" (58 trials), "Multiple Myeloma" (46 trials) and "Breast Cancer" (40 trials). Many other conditions were trialed in "Fred Hutchinson Cancer Research Center" in a lesser frequency.

Most popular intervention types in "Fred Hutchinson Cancer Research Center" are "Drug" (560 trials), "Biological" (212 trials), "Procedure" (169 trials), "Other" (166 trials) and "Radiation" (94 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (67 trials), "cyclophosphamide" (65 trials), "peripheral blood stem cell transplantation" (48 trials), "radiation therapy" (48 trials) and "filgrastim" (46 trials). Other intervention names were less common.

The vast majority of trials in "Fred Hutchinson Cancer Research Center" are 661 trials for "All" genders, 104 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Fred Hutchinson Cancer Research Center". undefined are not yet recruiting, 85 are recruiting, 129 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 490 completed trials in Fred Hutchinson Cancer Research Center, 2 suspended trials, and 54 terminated clinical trials to date.

Out of the total trials that were conducted in Fred Hutchinson Cancer Research Center, 164 "Phase 1" clinical trials were conducted, 368 "Phase 2" clinical trials and 211 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 63 trials that are defined as “Not Applicable".

Fred Hutchinson Cancer Research Center has several departments that took part in Clinical trials: "Seattle Vaccine and Prevention CRS" - 28 trials, "Puget Sound Oncology Consortium" - 24 trials, "Fred Hutchinson Cancer Research Center - Vaccine and Infectious Diseases" - 2 trials, "Cancer Immunotherapy Trials Network" - 2 trials